Study Finds Epigenetic Differences Between Hatchery-Raised and Wild-Born Salmon

The variation may help explain why stocked salmon don’t fare as well in the ocean.

Mar 1, 2018
Shawna Williams

HELD BACK: Pacific salmon raised in hatcheries, such as the Big Qualicum Hatchery in British Columbia, are less likely than wild-born fish to survive ocean life.DAVID WILLIS, SALMON ENHANCEMENT PROGRAM

When captive-bred Pacific salmon leave their hatcheries to swim free in the ocean, they soon take on the look of their wild counterparts, with the color of their sides changing from red to silver, the better to mesh with their new saltwater digs. But in important, less visible ways, the fish never shake the legacy of their domestic upbringing: They are less likely than wild-born salmon to survive in rivers and the ocean, and if they live long enough to reproduce, they produce fewer offspring.

Just what’s wrong with these hatchery-reared fish? With wild stocks on the decline and aquaculturists stepping in to try and bolster Pacific salmon populations, answering this question—and, if possible, increasing the fitness of hatchery-raised fish—has gained importance.

Some researchers suggest that hatchery rearing selects for alleles for certain traits, such as a tolerance for crowding, that make fish more likely to thrive in confinement, and that these same features work against the animals in the wild. One 2012 study of steelhead trout (Oncorhynchus mykiss) seemed to lend support to that theory, finding that the offspring of the most reproductively successful captive fish were the least likely to spawn successfully in the wild (PNAS, 109:238-42).

But biologist Louis Bernatchez of Quebec’s Laval University wasn’t satisfied with this genetic-adaptation explanation. In Canada’s Pacific salmon hatcheries, “there’s a lot of genetic exchange between hatchery fish and wild fish,” because wild-hatched fish sometimes stray into the hatcheries to spawn, and hatchery-reared fish may reproduce in the wild, he says. “It was hard to believe that selection alone could be involved in explaining the performance differences that we see between hatchery and wild.”

Quite a few important biological functions were affected.

—Louis Bernatchez,
Laval University, Quebec

So Bernatchez and his colleagues set out to search for evidence of a different kind of hatchery adaptation, detectable in the epigenome rather than the genome. They trapped juvenile coho salmon (Oncorhynchus kisutch) just before, or a few weeks after, release from hatcheries on two rivers in British Columbia, and wild juveniles from the same area. Then, they collected and sequenced samples of the fish’s muscle tissue. When they compared the two populations’ genomes, the researchers found no significant genetic differences. But compared to the genomes of their wild counterparts, 100 regions on the genomes of hatchery-reared salmon were differentially methylated, and of those, 89 were hypermethylated (PNAS, 114:12964-69, 2017).

“That’s a pretty clear-cut and striking result,” Bernatchez says, adding that the results imply “that those genes are downregulated, or less expressed, most likely, in the hatchery fish relative to wild fish.” Some of the hypermethylated regions contain genes for immunity, the transmission of neural signals to muscles for locomotion, and appetite and feeding behaviors. “Quite a few important biological functions were affected,” he adds, indicating that the methylation patterns may play into the fitness differences between wild and hatchery-reared fish.

NOSEDIVE: Wild populations of coho salmon (Oncorhynchus kisutch) have plummeted over the last few decades.BUREAU OF LAND MANAGEMENT OREGON AND WASHINGTON/FLICKR

“I think it’s a good first step” toward discovering whether the hatchery environment induces epigenetic change, says Mackenzie Gavery, a postdoc at the University of Washington and NOAA’s Northwest Fisheries Science Center who studies epigenetics in aquatic ecosystems and was not involved in the study. But it’s not clear whether the epigenetic differences found by the team persist over the years that the fish live in a shared environment, she says, and thus whether they could explain the persistent fitness differences between the two types of salmon.

“I think it’s a very important finding,” comments Erika Eliason, a comparative physiologist at the University of California, Santa Barbara. But, like Gavery, she thinks the case of the unfit hatchery salmon is far from closed. An important next step will be to look for direct evidence that the epigenetic differences have functional consequences, she says. She’d also like to see the analysis performed on other tissue types, such as the gill—an area crucial for fishes’ transition from freshwater to ocean living.

Bernatchez acknowledges that the study doesn’t draw a clear causal link between the epigenetic differences and survival. As another step in that direction, his group is now running a similar comparison on adult fish (hatchery-raised salmon have one of their smallest fins clipped before release so that they can be distinguished from wild-born salmon later). Answering the genetic vs. epigenetic question, and determining whether the epigenetic differences seen in hatchery fish are heritable, could be consequential for conservation efforts, he says, because heritable changes “would not disappear or vanish as easily as . . . if those changes were totally environmentally driven and not passed along from one generation to the next.” Altering aspects of the hatchery environment such as overcrowding and diet might help mitigate epigenetic changes, he says.

Gavery agrees that with greater understanding, it might be possible to manage hatcheries differently to boost fitness: “If it’s an epigenetic change, if you can figure out . . . [how] to reduce that impact, you can in essence make a better hatchery, make more-robust fish.”

July 2019

On Target

Researchers strive to make individualized medicine a reality


Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.